NEW YORK – Rapid in vitro diagnostic maker Biolytical recently received prequalification status from the World Health Organization for its 60-second HIV self-test to detect antibodies to the virus directly from whole blood finger-stick samples. The firm has also begun a national collaboration to evaluate HIV self-testing in Canada that will ultimately support regulatory efforts there, and it is looking into the home-use regulatory pathway in the US as well.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.